BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
+11.92%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$1.61B
AUM Growth
+$1.61B
(+5.6%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
8.61%
Top 10 Holdings %
Top 10 Hldgs %
76.11%
Holding
34
New
4
Increased
2
Reduced
3
Closed
1
Top Buys
| 1 |
Rapid Micro Biosystems
RPID
|
$156M |
| 2 |
Invivyd
IVVD
|
$105M |
| 3 |
Nuvalent
NUVL
|
$77.3M |
| 4 |
Tango Therapeutics
TNGX
|
$12.9M |
| 5 |
ARYE
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
|
$4.94M |
Top Sells
| 1 |
Atea Pharmaceuticals
AVIR
|
$67.2M |
| 2 |
Dynavax Technologies
DVAX
|
$64.5M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$63.4M |
| 4 |
Kymera Therapeutics
KYMR
|
$23.3M |
Sector Composition
| 1 | Healthcare | 92.57% |
| 2 | Financials | 2.38% |
